Cardiff University | Prifysgol Caerdydd ORCA
Online Research @ Cardiff 
WelshClear Cookie - decide language by browser settings

Computer-aided discovery of small-molecule inhibitors of pathogenic new world arenavirus entry and replication

Wasson, Samantha Rae, Flude, Ben Matthew, Salerno, Martina, Jung, Kie Hoon, Padalino, Gilda, Ferla, Salvatore, Roche-Dugmore, Dylan Joseph, Bott, Connor W, Brancale, Andrea, Gowen, Brian B. and Bassetto, Marcella ORCID: https://orcid.org/0000-0002-2491-5868 2026. Computer-aided discovery of small-molecule inhibitors of pathogenic new world arenavirus entry and replication. ACS Infectious Diseases 12 (6) , pp. 2046-2059. 10.1021/acsinfecdis.6c00138

[thumbnail of computer-aided-discovery-of-small-molecule-inhibitors-of-pathogenic-new-world-arenavirus-entry-and-replication.pdf] PDF - Published Version
Available under License Creative Commons Attribution.

Download (14MB)

Abstract

Pathogenic New World arenaviruses (NWAs), including Junín (JUNV) and Machupo (MACV) viruses, rely on host–virus entry processes that represent attractive points for antiviral intervention. Guided by the known use of human transferrin receptor 1 (hTfR1) by several NWAs for cell entry, we conducted a structure-based virtual screening campaign targeting the MACV GP1-hTfR1 interaction interface to identify small molecules capable of inhibiting early infection. From an in silico screen of commercially available drug-like compounds, 25 candidates were selected and tested in cell-based assays, yielding two chemically distinct scaffolds with low-micromolar activity against JUNV. Hit expansion of the primary chemotype produced 107 new analogues, several of which achieved submicromolar inhibition of JUNV replication. Among them, compound 22f demonstrated antiviral activity across multiple arenaviruses, including both hTfR1-tropic NWAs and viruses that use alternative entry pathways, while showing no effect on the unrelated Rift Valley fever virus. In an hTfR1-expressing mouse model of JUNV infection, 22f was well tolerated, but did not confer protection. These results provide the foundation for further development and optimization of potent compounds that broadly inhibit infection by the pathogenic NWAs.

Item Type: Article
Date Type: Publication
Status: Published
Schools: Schools > Pharmacy
Publisher: American Chemical Society
ISSN: 2373-8227
Date of First Compliant Deposit: 11 May 2026
Date of Acceptance: 27 April 2026
Last Modified: 13 Jul 2026 12:50
URI: https://orca.cardiff.ac.uk/id/eprint/186922

Actions (repository staff only)

Edit Item Edit Item

Downloads

Downloads per month over past year

View more statistics